dr. visco on next steps for the mante-first trial in relapsed/refractory mcl
Published 3 years ago • 71 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
0:54
dr. visco on the rationale for the mantle-first trial in r/r mcl
-
0:57
dr. visco on the utility of bendamustine in mcl
-
0:48
dr. visco on the utility of cytarabine in mcl
-
2:06
the role of venetoclax in r/r mcl & options for patients who progress on venetoclax
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
4:41
answers from the experts: cutaneous b-cell lymphoma variants
-
8:43
basics about peripheral t-cell lymphoma
-
1:22
dr. zonder on the zuma-2 and zuma-5 trials in mcl and inhl
-
1:43
ongoing clinical trials to look out for in lymphoma
-
1:43
updates on the use of bispecific antibodies in mcl & the need for more studies in this space
-
3:45
real-world outcomes of brexu-cel in patients with r/r mcl
-
3:33
how can diffuse large b-cell lymphoma treatment symptoms be managed?
-
3:34
transcend study: liso-cel shows promise in r/r mcl patients
-
1:00
updates on glofitamab in mcl
-
4:03
hot topics in lymphoma in 2020
-
1:39
what has been the major development in the treatment of t cell lymphoma?
-
5:50
venetoclax and r2 in mantle cell lymphoma
-
2:31
optimizing treatment of mcl
-
58:44
probing the myeloma immune microenvironment one cell at a time (single-cell sequencing)
-
0:47
real-world outcomes of brexu-cel in patients with r/r mcl
-
6:00
mantle cell lymphoma: improved prognosis